Generation of hematopoietic cells from mouse pluripotent stem cells in a 3D culture system of self-assembling peptide hydrogel.
Animals
Biomarkers
/ metabolism
Cell Culture Techniques
/ methods
Cell Differentiation
/ drug effects
Colony-Forming Units Assay
/ methods
Graft vs Host Disease
/ metabolism
Hematopoietic Stem Cell Transplantation
/ methods
Hematopoietic Stem Cells
/ cytology
Hydrogels
/ administration & dosage
Mice
Mice, Inbred C57BL
Mice, Inbred ICR
Mice, Inbred NOD
Mice, SCID
Pluripotent Stem Cells
/ cytology
hematopoietic differentiation
mouse pluripotent stem cells
three dimension self-assembling peptide hydrogel
Journal
Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
06
01
2018
accepted:
25
01
2018
pubmed:
8
8
2019
medline:
16
12
2020
entrez:
8
8
2019
Statut:
ppublish
Résumé
In vitro generation of hematopoietic stem cells from pluripotent stem cells (PSCs) can be regarded as novel therapeutic approaches for replacing bone marrow transplantation without immune rejection or graft versus host disease. To date, many different approaches have been evaluated in terms of directing PSCs toward different hematopoietic cell types, yet, low efficiency and no function restrict the further hematopoietic differentiation study, our research aims to develop a three dimension (3D) hematopoietic differentiation approach that serves as recapitulation of embryonic development in vitro to a degree of complexity not achievable in a two dimension culture system. We first found that mouse PSCs could be efficiently induced to hematopoietic differentiation with an expression of hematopoietic makers, such as c-kit, CD41, and CD45 within self-assembling peptide hydrogel. Colony-forming cells assay results suggested mouse PSCs (mPSCs) could be differentiated into multipotential progenitor cells and 3D induction system derived hematopoietic colonies owned potential of differentiating into lymphocyte cells. In addition, in vivo animal transplantation experiment showed that mPSCs (CD45.2) could be embedded into nonobese diabetic/severe combined immunodeficiency mice (CD45.1) with about 3% engraftment efficiency after 3 weeks transplantation. This study demonstrated that we developed the 3D induction approach that could efficiently promote the hematopoietic differentiation of mPSCs in vitro and obtained the multipotential progenitors that possessed the short-term engraftment potential.
Substances chimiques
Biomarkers
0
Hydrogels
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2080-2090Informations de copyright
© 2019 Wiley Periodicals, Inc.